(Press-News.org) New Rochelle, NY, November 5, 2012—At least 2 million people worldwide will be infected with HIV this year, driving the need for better HIV prevention strategies to slow the global pandemic. A better understanding of how to prevent HIV transmission using antiviral drugs led to approval of the first oral pill for HIV prevention, and microbicides delivered as topical gels or via intravaginal rings are in clinical testing and have yielded both positive and negative results. The complex factors involved in the sexual transmission of HIV, the urgent need for new preventive approaches, and the most promising methods currently in development are examined in a special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc, publishers. The entire issue is available free on the AIDS Research and Human Retroviruses website at http://www.liebertpub.com/aid.
Guest Editor Patrick Kiser, University of Utah, Salt Lake City, and coauthors Pedro Mesquita and Betsy Herold, Albert Einstein College of Medicine, New York, NY, provide an overview of the scientific and developmental gaps in the field of drug discovery, formulation, and delivery to prevent sexual transmission of HIV. In the article "A Perspective on Progress and Gaps in HIV Prevention Science," they review the prophylactic agents in development and their advantages and limitations, and they present recommendations for future research directions. "The advances we are seeing today are exciting and justify a continued focus on the science and technologies that can make a difference in this public health crisis," says Dr. Kiser.
Peter Anton and coauthors, David Geffen School of Medicine at UCLA and the School of Public Health (Los Angeles, CA), University of Pittsburgh and Medical School (PA), University of North Carolina, Chapel Hill, Johns Hopkins University School of Medicine (Baltimore, MD), Alpha StatConsult (Damascus, MD), Columbia University (New York, NY), and CONRAD (Arlington, VA), compared the oral and topical administration of the microbicide tenofovir, given as a pill or rectal gel. A mucosal tissue sample was removed from each participant and exposed to HIV to assess if treatment prevented infection. While the patients preferred the oral drug, one-time rectal exposure to the microbicide led to 6-10 times greater drug concentrations in the sampled tissue, and this correlates with reduced infectibility.
The methods and materials used to administer microbicidal drugs can affect whether or not they will be effective. Meropi Aravantinou et al. (Population Council and Rockefeller University, New York, NY; Tulane University, Covington, LA; National Cancer Institute, Frederick, MD) demonstrate this in the article "The Nonnucleoside Reverse Transcription Inhibitor MIV-160 Delivered from an Intravaginal Ring, But Not from a Carrageenan Gel, Protects Against Simian/Human Immunodeficiency Virus-RT Infection."
Line Vibholm and colleagues from Aarhus University and Aarhus University Hospital, Denmark, present the results of a study designed to evaluate in a female mouse model the effects of a topical gel containing 1% tenofovir, a microbicide previously shown to reduce substantially the transmission of both HIV and herpes simplex virus (HSV). In "Antiviral and Immunological Effects of Tenofovir Microbicide in Vaginal Herpes Simplex Virus 2 Infection," the authors provide data to support the suitability of this model for testing future microbicidal drug candidates.
"It is currently an exciting time in HIV prevention science research, with progress on multiple fronts," says Thomas Hope, PhD, Editor-in-Chief of AIDS Research and Human Retroviruses and Professor of Cell and Molecular Biology at the Feinberg School of Medicine, Northwestern University, Chicago, IL. "We are proud to feature this work in the special issue and, in the future, to report critical advances to bring the field closer to the goal of decreasing the rate of HIV transmission around the world."
INFORMATION:
About the Journal
AIDS Research and Human Retroviruses is published monthly in print and online. It contains papers, reviews, and case studies documenting the latest developments and research advances in the molecular biology of HIV and SIV and innovative approaches to HIV vaccine and therapeutic drug research, including the development of antiretroviral agents and immune-restorative therapies. The content also explores the molecular and cellular basis of HIV pathogenesis and HIV/HTLV epidemiology. The Journal features rapid publication of emerging sequence information and reports on clinical trials of emerging HIV therapies. Tables of content and a sample issue may be viewed on the AIDS Research and Human Retroviruses website at http://www.liebertpub.com/aid.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including AIDS Patient Care and STDs, Viral Immunology, and Journal of Interferon and Cytokine Research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
HIV and AIDS prevention--Progress and the challenges ahead
2012-11-06
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Imaging facility develops successful radiation dose reduction program
2012-11-06
According to an article in the November issue of the Journal of the American College of Radiology, a medical imaging facility in San Diego, Imaging Healthcare Specialists, has implemented a successful radiation dose reduction program, reducing radiation exposure by up to 90 percent in some patients.
"In the past decade, there have been unparalleled technological advances and growth in CT imaging, with many lives saved and more costly and invasive procedures avoided. This growth in CT imaging, however, has also been accompanied by an unavoidable increase in cumulative ...
November 2012 story tips
2012-11-06
ENVIRONMENT – Ozone affecting watersheds . . .
U.S. Forest Service and Oak Ridge National Laboratory scientists have found that rising levels of ozone may amplify the impacts of higher temperatures and reduce streamflow from forests to rivers, streams and other water bodies. Such effects could potentially reduce water supplies available to support forest ecosystems and people in the southeastern United States. Using data on atmospheric water supply and demand and statistical models, researchers with the Forest Service and ORNL were able to show what effects ozone, categorized ...
Bypass surgery improves survival for patients with diabetes and multi-vessel coronary artery disease
2012-11-06
(Toronto – Nov. 4, 2012) – An international, clinical research trial has shown that patients with diabetes whose multi-vessel coronary artery disease is treated with bypass surgery live longer and are less likely to suffer severe complications like heart attacks than those who undergo angioplasty.
The findings are published online today in The New England Journal of Medicine (10.1056/NEJMoa1211585). The study – co-led by researchers at New York's Mount Sinai Hospital and Toronto's Peter Munk Cardiac Centre, University Health Network (UHN) – is known as the FREEDOM trial.
"We've ...
Scripps studies show community-based diabetes programs are key to lowered costs and improved care
2012-11-06
LA JOLLA, Calif. – New findings from a 15-year series of studies led by care providers at Scripps Whittier Diabetes Institute reveal that culturally tailored community-created programs are effective at reducing health-related costs and delivering higher quality care.
Results from "Community-Created Programs: Can They Be the Basis of Innovative Transformations in Our Health Care Practice?" were published in the fall issue of Clinical Diabetes, and also posted on its website. The journal article discusses the results of a series of studies involving approximately 18,000 ...
Healthy living adds 14 years to your life
2012-11-06
CHICAGO --- If you have optimal heart health in middle age, you may live up to 14 years longer, free of cardiovascular disease, than your peers who have two or more cardiovascular disease (CVD) risk factors, according to a new Northwestern Medicine study.
The study was published Nov. 5 in the Journal of the American Medical Association (JAMA).
"We found that many people develop cardiovascular disease as they live into old age, but those with optimal risk factor levels live disease-free longer," said John T. Wilkins, M.D., first author of the study. "We need to do everything ...
Children's preexisting symptoms influence their reactions to disaster coverage on TV
2012-11-06
After a natural disaster occurs, we often find ourselves glued to the TV, seeking out details about the extent of the damage and efforts at recovery. While research has shown that exposure to this kind of coverage is associated with symptoms of traumatic stress in youths, new research published in Psychological Science, a journal of the Association for Psychological Science, suggests that the relationship isn't quite so simple. The new study finds that while the amount of exposure to disaster coverage matters, children's preexisting symptoms of posttraumatic stress also ...
Therapy with bone marrow-derived stem cells does not improve short-term recovery after heart attack
2012-11-06
Administering to patients stem cells derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health.
The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous, related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function. Both TIME and LateTIME were conducted by ...
Drought in 2001-2002 fueled Rocky Mountain pine beetle outbreak
2012-11-06
Results of a new study show that episodes of reduced precipitation in the Southern Rocky Mountains, especially during the 2001-2002 drought, greatly accelerated a rise in numbers of mountain pine beetles. The overabundance is a threat to regional forests.
The research is the first to chart the evolution of the current pine beetle epidemic in the southern Rocky Mountains.
It compared patterns of beetle outbreaks in the two primary host species, the ponderosa pine and lodgepole pine, said University of Colorado at Boulder (CU-Boulder) researcher Teresa Chapman.
A paper ...
Controlling vascular disease may be key to reducing prevalence of Alzheimer's disease
2012-11-06
Amsterdam, NL, November 5, 2012 – Over the last 15 years, researchers have found a significant association between vascular diseases such as hypertension, atherosclerosis, diabetes type 2, hyperlipidemia, and heart disease and an increased risk of Alzheimer's disease. In a special issue of the Journal of Alzheimer's Disease, leading experts provide a comprehensive overview of the pathological, biochemical, and physiological processes that contribute to Alzheimer's disease risk and ways that may delay or reverse these age-related abnormalities.
"Vascular risk factors ...
Stirred not mixed: How seawater turbulence affects marine food webs
2012-11-06
New research shows that ocean turbulence directly affects the ability of microscopic marine organisms to recycle organic material back into the food web.
Results of the study are published in this week's issue of the journal Science.
Scientists John Taylor of Cambridge University and Roman Stocker at MIT found that there's a relationship between the natural movement of water in the ocean and the ability of marine bacteria to act as recyclers.
"The research provides a unique insight into how small organisms, such as bacteria, interact with their environment," says ...